Halozyme Therapeutics shares owned by Voloridge Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Voloridge Investment Management
from 13F filings
Historical chart of Voloridge Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Voloridge Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Voloridge Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $16M | 398k | 40.68 |
| 2023-12-31 | $2.0M | 55k | 36.96 |
| 2022-12-31 | $12M | 212k | 56.90 |
| 2022-09-30 | $2.8M | 71k | 39.53 |
| 2022-06-30 | $16M | 368k | 44.00 |
| 2022-03-31 | $5.7M | 143k | 39.88 |
| 2021-12-31 | $10M | 256k | 40.21 |
| 2021-09-30 | $4.6M | 114k | 40.68 |
| 2020-12-31 | $8.7M | 204k | 42.71 |
| 2020-09-30 | $9.8M | 373k | 26.28 |
| 2020-06-30 | $7.9M | 295k | 26.81 |
| 2019-12-31 | $1.8M | 99k | 17.73 |
More positions owned by Voloridge Investment Management
Cigna Corp (CI)
View all positions for Voloridge Investment Management